282 related articles for article (PubMed ID: 33121537)
1. iCREATE: imaging features of primary and metastatic alveolar soft part sarcoma from the EORTC CREATE study.
Mcaddy NC; Saffar H; Litière S; Jespers P; Schöffski P; Messiou C
Cancer Imaging; 2020 Oct; 20(1):79. PubMed ID: 33121537
[TBL] [Abstract][Full Text] [Related]
2. Imaging features of primary and metastatic alveolar soft part sarcoma: single institute experience in 25 patients.
Sood S; Baheti AD; Shinagare AB; Jagannathan JP; Hornick JL; Ramaiya NH; Tirumani SH
Br J Radiol; 2014 Apr; 87(1036):20130719. PubMed ID: 24641199
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
Lee CJ; Modave E; Boeckx B; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Debiec-Rychter M; Sciot R; Lambrechts D; Wozniak A; Schöffski P
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628499
[TBL] [Abstract][Full Text] [Related]
4. Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.
Schöffski P; Wozniak A; Kasper B; Aamdal S; Leahy MG; Rutkowski P; Bauer S; Gelderblom H; Italiano A; Lindner LH; Hennig I; Strauss S; Zakotnik B; Anthoney A; Albiges L; Blay JY; Reichardt P; Sufliarsky J; van der Graaf WTA; Debiec-Rychter M; Sciot R; Van Cann T; Marréaud S; Raveloarivahy T; Collette S; Stacchiotti S
Ann Oncol; 2018 Mar; 29(3):758-765. PubMed ID: 29216400
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.
Paoluzzi L; Maki RG
JAMA Oncol; 2019 Feb; 5(2):254-260. PubMed ID: 30347044
[TBL] [Abstract][Full Text] [Related]
6. Alveolar soft part sarcoma metastatic to the breast: a case report.
Asano Y; Kashiwagi S; Takada K; Tokimasa S; Takashima T; Ohsawa M; Hirakawa K; Ohira M
BMC Surg; 2019 Mar; 19(1):30. PubMed ID: 30832622
[TBL] [Abstract][Full Text] [Related]
7. Primary intraosseous alveolar soft part sarcoma: Report of two cases with radiologic-pathologic correlation.
Pena-Burgos EM; Pozo-Kreilinger JJ; Tapia-Viñe M; Redondo A; Mendiola-Sabio M; Ortiz-Cruz EJ
Ann Diagn Pathol; 2023 Feb; 62():152078. PubMed ID: 36543620
[TBL] [Abstract][Full Text] [Related]
8. Advanced alveolar soft part sarcoma responds to apatinib.
Zhou Y; Tang F; Wang Y; Min L; Luo Y; Zhang W; Shi R; Duan H; Tu C
Oncotarget; 2017 Jul; 8(30):50314-50322. PubMed ID: 28679123
[TBL] [Abstract][Full Text] [Related]
9. Treatment of a case of primary alveolar soft part sarcoma of the lung: Case report and literature review.
Li F; Lu H; Zhao D; Shen Z
J Int Med Res; 2023 Jun; 51(6):3000605231174973. PubMed ID: 37282499
[TBL] [Abstract][Full Text] [Related]
10. Alveolar soft part sarcoma of the retro peritoneum.
Xin FY; Rana N; Ming Z; Lang YB
J Cancer Res Ther; 2010; 6(1):117-9. PubMed ID: 20479565
[TBL] [Abstract][Full Text] [Related]
11. Alveolar soft part sarcoma: progress toward improvement in survival? A population-based study.
Fujiwara T; Nakata E; Kunisada T; Ozaki T; Kawai A
BMC Cancer; 2022 Aug; 22(1):891. PubMed ID: 35971085
[TBL] [Abstract][Full Text] [Related]
12. Fine needle aspiration of alveolar soft part sarcoma in a child: Cytomorphological clues for the surgical pathologist.
Mostafa M; Abbott D; Parsons LN
Ann Diagn Pathol; 2018 Jun; 34():85-88. PubMed ID: 29661735
[TBL] [Abstract][Full Text] [Related]
13. Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
Malouf GG; Beinse G; Adam J; Mir O; Chamseddine AN; Terrier P; Honore C; Spano JP; Italiano A; Kurtz JE; Coindre JM; Blay JY; Le Cesne A
Oncologist; 2019 Jul; 24(7):980-988. PubMed ID: 30626710
[TBL] [Abstract][Full Text] [Related]
14. Alveolar soft-part sarcoma: a rare soft-tissue malignancy with distinctive clinical and radiological features.
Pang LM; Roebuck DJ; Griffith JF; Kumta SM; Metreweli C
Pediatr Radiol; 2001 Mar; 31(3):196-9. PubMed ID: 11297086
[TBL] [Abstract][Full Text] [Related]
15. Alveolar soft-part sarcoma of the orbit.
Rose AM; Kabiru J; Rose GE
Afr J Paediatr Surg; 2011; 8(1):82-4. PubMed ID: 21478594
[TBL] [Abstract][Full Text] [Related]
16. Detection of ASPL/TFE3 fusion transcripts and the TFE3 antigen in formalin-fixed, paraffin-embedded tissue in a series of 18 cases of alveolar soft part sarcoma: useful diagnostic tools in cases with unusual histological features.
Williams A; Bartle G; Sumathi VP; Meis JM; Mangham DC; Grimer RJ; Kindblom LG
Virchows Arch; 2011 Mar; 458(3):291-300. PubMed ID: 21279521
[TBL] [Abstract][Full Text] [Related]
17. Paediatric and adolescent alveolar soft part sarcoma: A joint series from European cooperative groups.
Orbach D; Brennan B; Casanova M; Bergeron C; Mosseri V; Francotte N; Van Noesel M; Rey A; Bisogno G; Pierron G; Ferrari A
Pediatr Blood Cancer; 2013 Nov; 60(11):1826-32. PubMed ID: 23857870
[TBL] [Abstract][Full Text] [Related]
18. Alveolar soft part sarcoma metastatic to the mandible: A report and review of literature.
Peters SM; Perrino MA; Yoon AJ; Philipone EM
J Stomatol Oral Maxillofac Surg; 2017 Dec; 118(6):379-382. PubMed ID: 28774857
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Features and Characteristic Vascular Pattern of Alveolar Soft-Part Sarcoma.
Cui JF; Chen HS; Hao DP; Liu JH; Hou F; Xu WJ
Oncol Res Treat; 2017; 40(10):580-585. PubMed ID: 28950275
[TBL] [Abstract][Full Text] [Related]
20. Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial.
Judson I; Morden JP; Kilburn L; Leahy M; Benson C; Bhadri V; Campbell-Hewson Q; Cubedo R; Dangoor A; Fox L; Hennig I; Jarman K; Joubert W; Kernaghan S; López Pousa A; McNeil C; Seddon B; Snowdon C; Tattersall M; Toms C; Martinez Trufero J; Bliss JM
Lancet Oncol; 2019 Jul; 20(7):1023-1034. PubMed ID: 31160249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
